West Pharmaceutical Services (WST)
EBITDA Margin
25.83%
Quarterly · Period ending:
WST EBITDA Margin
Latest reported25.83%period ending
Latest reported25.83%period ending
WST Quarterly EBITDA Margin (100.00% → 25.83%)
Quarterly ebitda margin
High-resolution chart · PNG
WST ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 18.686% | |
| 9.6386% | |
| 5.3232% | |
| 7.9426% | |
| 9.9379% | |
| 10.0279% | |
| 11.9584% | |
| 13.119% | |
| 16.1576% | |
| 15.2364% | |
| 39.9826% | |
| 14.1352% | |
| 14.1623% | |
| -13.0228% | |
| 15.6164% | |
| 12.0722% | |
| 13.9724% | |
| 12.816% | |
| 13.7871% | |
| 10.3324% | |
| 11.5966% | |
| 10.7112% | |
| 10.316% | |
| 8.0119% | |
| 12.6606% | |
| 16.0714% | |
| 11.0999% | |
| 11.2128% | |
| 14.0984% | |
| 15.3846% | |
| 12.7155% | |
| 10.989% | |
| 12.744% | |
| 10.5869% | |
| 9.276% | |
| 9.7171% | |
| 13.7255% | |
| 13.9364% | |
| -30.7786% | |
| 9.4221% | |
| 9.4132% | |
| 10.3368% | |
| 0.6219% | |
| 7.4122% | |
| 7.0646% | |
| 11.3365% | |
| -242.0326% | |
| 100% | |
| 100% | |
| 100% | |
| -241.9098% | |
| 100% | |
| 100% | |
| 100% | |
| -235.9398% | |
| 100% | |
| 100% | |
| 100% | |
| -235.1882% | |
| 100% | |
| 100% | |
| 100% | |
| -249.2662% | |
| 100% |